Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Organ Preservation Solution Market Size And Revenue Outlook Through 2030
The organ preservation solution market has shown robust expansion in recent years. It is anticipated to increase from $0.31 billion in 2025 to $0.33 billion in 2026, with a compound annual growth rate (CAGR) of 6.7%. Historically, this market’s growth can be linked to the rise in organ transplantation procedures, the broadening of transplant infrastructure, enhanced availability of preservation solutions, the adoption of cold storage techniques, and progress in medical preservation chemistry.
The organ preservation solution market size is anticipated to undergo significant expansion over the next few years, with projections indicating it will reach $0.43 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8%. This growth during the forecast period is primarily driven by the increasing demand for organ transplants, the rising adoption of advanced preservation technologies, the expansion of machine perfusion systems, an escalating focus on transplant success rates, and innovations in organ protection formulations. Key trends influencing the market during this period include advancements in ischemia-reperfusion injury mitigation, the growing implementation of machine perfusion techniques, the increasing utilization of multi-organ preservation solutions, extended transplant storage durations, and an enhanced emphasis on organ viability.
Get A Free Sample Report With In-Depth Market Insights:
Organ Preservation Solution Market Expansion Drivers: What’s Shaping Future Growth?
The expansion of the organ preservation solution market is being fueled by an upsurge in healthcare spending, which refers to the total financial resources dedicated to the healthcare sector within a particular region, country, or organization. These funds are vital for utilizing organ preservation solutions, which in turn optimize the success rate of organ transplantation procedures. These essential solutions maintain the viability of organs during transport and storage for successful transplantation. Such investment significantly improves organ transplant outcomes, potentially decreasing the overall need for transplantation and associated healthcare expenditures. For instance, in November 2023, the Canadian Institute for Health Information reported that total health spending in Canada for 2023 is projected to hit $344 billion, or $8,740 per person. This represents a 2.8% increase from the prior year, a notable jump compared to the mere 1.5% growth in health spending seen in 2022, highlighting a strong recovery in healthcare investment. Thus, increasing healthcare spending is poised to drive the growth of the organ preservation solution market moving forward.
Organ Preservation Solution Market Segment Breakdown: Which Categories Lead On Revenue?
The organ preservation solution market covered in this report is segmented –
1) By Solution Type: Viaspan, Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate), Hypothermosol, Perfadex, Other Solution Types
2) By Organ Type: Kidneys, Liver, Lung, Heart, Other Organ Types
3) By Technique: Static Cold Storage (SCS) Technique, Hypothermic Machine Perfusion, Other Techniques
Subsegments:
1) By Viaspan: Standard Viaspan, Modified Viaspan Formulations
2) By Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate): Custodiol Formulations: Variants With Additives
3) By Hypothermosol: Hypothermosol For Various Organs, Custom Hypothermosol Mixes
4) By Perfadex: Perfadex For Lung Preservation, Adapted Perfadex Formulations
5) By Other Solution Types: Experimental Preservation Solutions, Emerging Organ Preservation Technologies
Organ Preservation Solution Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies in the organ preservation solution market are concentrating on developing innovative products to strengthen their position and gain a competitive advantage. For instance, in June 2024, Paragonix Technologies, a US-based organ preservation technology company, introduced its PancreasPak Organ Preservation System. This device is the first FDA-cleared system specifically engineered to safeguard and monitor donor pancreases during transportation, highlighting its significance in organ transplantation. The system provides a controlled environment, maintaining the pancreas within an optimal thermal range of 4-8°C, which is crucial for preserving the organ’s viability and functionality during transport that can last up to 21 hours. PancreasPak is equipped with digital monitoring features that continuously track the temperature and surrounding conditions of the pancreas. This real-time data enables quick responses to any deviations from optimal conditions, thereby improving organ preservation.
Organ Preservation Solution Market Leading Players And Competitive Positioning
Major companies operating in the organ preservation solution market are Bridge to Life, XVIVO Perfusion, Organ Recovery Systems, Dr. Franz Köhler Chemie, BioLife Solutions, Essential Pharmaceuticals, Preservation Solutions, KPS Life, Hibernicor, Advanced Organ Biosciences, Paragonix Technologies, TransMedics, OrganOx, Organ Assist, XVIVO Lung Perfusion, Cell and Tissue Systems, Sustained Medical, Organ Preservation Alliance, Lifeline Scientific, Arthrex
View The Full Organ Preservation Solution Market Report:
Organ Preservation Solution Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in the organ preservation solution market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organ preservation solution market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
